البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
TYLOSIN AS TARTRATE
BIOVAC LTD., ISRAEL
POWDER SOLUBLE
TYLOSIN AS TARTRATE 90.9 %W/W
PER OS IN DRINKING WATER
Required
BIOVAC LTD., ISRAEL
Chickens: Treatment and prevention of chronic respiratory diseases (CRD) caused by Mycoplasma gallisepticum and Mycoplasma synoviae when the disease has been established in the flock.Treatment and prevention of necrotic enteritis caused by Clostridium perfringens when the disease has been established in the flockTurkeys: Treatment and prevention of infectious sinusitis caused by Mycoplasma gallisepticum. when the disease has been established in the flock
2022-12-31
Page 1 of 4 CONSUMER LEAFLET FOR A VETERINARY PRODUCT This medicine is marketed according to a veterinarian’s prescription only. For animal use only 1. NAME OF THE VETERINARY MEDICINE, FORM AND STRENGTH TYLOGAL POWDER VETERINARY, soluble powder for dissolution in drinking water, containing TYLOSIN (AS TARTRATE salt) 90.9% W/W 2. ACTIVE INGREDIENT AND QUANTITY IN A SINGLE DOSE TYLOSIN (AS TARTRATE) 90.9 %W/W Equivalent to 100% tylosin tartrate 3. WHAT IS THE MEDICINE INTENDED FOR Chickens: - Treatment and prevention of chronic respiratory diseases (CRD) caused by _Mycoplasma _ _gallisepticum_ and _Mycoplasma synoviae _when the disease has been established in the flock. - Treatment and prevention of necrotic enteritis caused by _Clostridium perfringens_ when the disease has been established in the flock. _ _ Turkeys: Treatment and prevention of infectious sinusitis caused by _Mycoplasma gallisepticum_ when the disease has been established in the flock. Therapeutic group: Antibiotic of the macrolide group. 4. CONTRA-INDICATIONS Do not use in in case of known hypersensitivity to tylosin or other macrolides. Do not use in cases of known resistance to tylosin or cross-resistance to other macrolides. Do not use in animals vaccinated with tylosin-sensitive vaccines either at the same time or within 1 week previously. Do not use in animals with hepatic disorders. 5. SIDE EFFECTS Side effects can be reported to the Ministry of Health by clicking on the link "Adverse Drug Reactions Repot" that appears on the home page of the Ministry of Health web site (www.health.gov.il), which leads to an online form for reporting side effects. Alternatively you can use the following link: HTTPS://SIDEEFFECTS.HEALTH.GOV.IL/ 6. TARGET ANIMALS: Chickens, turkeys 7. DOSAGE AND ADMINISTRATION Administration through the drinking water. 1.1 gram of the product corresponds to 1 gram of tylosin. The Dosages: Turkeys: 75 – 100 mg tylosin per kg BW per day (corresponding to 82.5 – 110 mg of the product per Page 2 of 4 kg BW) for 3 – 5 days. اقرأ الوثيقة كاملة
Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT TYLOGAL POWDER VETERINARY 2. QUALITATIVE AND QUANTITATIVE COMPOSITION TYLOSIN AS TARTRATE 90.9 %W/W Equivalent to 100% tylosin tartrate 3. PHARMACEUTICAL FORM POWDER SOLUBLE IN DRINKING WATER . 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens, turkeys 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Chickens: Treatment and prevention of chronic respiratory diseases (CRD) caused by _Mycoplasma _ _gallisepticum_ and _Mycoplasma _ _synoviae _ when the disease has been established in the flock. Treatment and prevention of necrotic enteritis caused by _Clostridium perfringens_ when the disease has been established in the flock _ _ Turkeys: Treatment and prevention of infectious sinusitis caused by _Mycoplasma _ _gallisepticum. _when the disease has been established in the flock 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to tylosin or other macrolides. Do not use in cases of known resistance to tylosin or cross-resistance to other macrolides (MLS-resistance). Do not use in animals vaccinated with tylosin-sensitive vaccines either at the same time or within 1 week previously. Do not use in animals with hepatic disorders. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Page 2 of 5 Due to likely variability (time, geographical) in susceptibility of bacteria to tylosin, bacteriological sampling and susceptibility testing are recommended. Under-dosing and/or treating for an insufficient length of time are considered to promote the development of resistance in bacteria and should be avoided. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Animals with acute infections may have a reduced water and feed consumption and should be treated with a suitable injectable veterinary medicinal product first. Do not leave or dispose of water containing tylosin tartrate where it may be accessible to either animals not under treatment or wildlife. Special precautions for the person administeri اقرأ الوثيقة كاملة